| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| FQ2 '27 | 11/9/267:00 AM | -$0.72 | -$0.47GAAP | +34.7% | +36% | — | $0 | — | — | |
| FQ1 '27 | 8/6/267:00 AM | -$0.52 | -$0.75GAAP | -44.2% | -6% | — | $0 | — | — | |
| FQ4 '26 | 5/20/267:00 AM | -$0.62 | -$0.73GAAP | -17.7% | -14% | — | $0 | — | — | |
| FQ3 '26 | 2/6/267:00 AM | -$0.71 | -$0.61GAAP | +14.1% | +20% | $2.40M | $0 | ⚠ Check | — | |
| FQ2 '26 | 11/10/257:00 AM | -$0.72 | -$0.73GAAP | -1.4% | +1% | — | $0 | — | — | |
| FQ1 '26 | 8/11/257:00 AM | -$0.68 | -$0.71GAAP | -4.4% | -18% | — | $0 | — | — | |
| FQ4 '25 | 5/29/257:00 AM | -$0.72 | -$0.64GAAP | +11.1% | -23% | — | $0 | — | — |
⚠ Potential error in calculation, check manually. Reported revenue shows as zero, which usually means the figure is missing.
GAAP = diluted EPS as filed with the SEC.